The efficacy and safety of cannabidiol as adjunct treatment for drug‐resistant idiopathic epilepsy in 51 dogs: A double‐blinded crossover study

The efficacy and safety of cannabidiol as adjunct treatment for drug‐resistant idiopathic epilepsy in 51 dogs: A double‐blinded crossover study

Abstract Background Approximately 30% of dogs with idiopathic epilepsy (IE) are drug‐resistant. Recent studies have suggested cannabidiol (CBD) may be an effective anticonvulsant in dogs with IE. Objective To evaluate the addition of CBD to antiseizure drugs (ASDs) on seizure frequency and to report...

Full description

Bibliographic Details
Main Authors: Aaron J. Rozental, Brooke G. Weisbeck, Isabella Corsato Alvarenga, Daniel L. Gustafson, Breonna R. Kusick, Sangeeta Rao, Lisa R. Bartner, Stephanie McGrath
Format: Article
Language:English
Published: Wiley 2023-11-01
Series:Journal of Veterinary Internal Medicine
Subjects:
canine
cannabis
CBD
epileptic
seizures
Online Access:https://doi.org/10.1111/jvim.16912

Internet

https://doi.org/10.1111/jvim.16912

Similar Items